Orient Europharma Co Ltd (4120):企業の財務・戦略的SWOT分析

◆英語タイトル:Orient Europharma Co Ltd (4120) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH68661FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Orient Europharma Co Ltd (OEP) is a pharmaceutical company that manufactures and markets prescription medication, Innovative medical and Infant health products. The company’s prescription medication products include cardiovascular medication, immunology medicine, metabolism medicine, neurology medication, gynecological medication, respiratory medication, and cancer treatment. It also provides oncology product such as anti-cancer drugs. OEP offers medical cosmetology products such as bio-oil and dermo-cosmetic products and nutrition products include health, nutrition, and baby care supplements. The company operates through its offices located in Hong Kong, China, the Philippines, Malaysia, Taiwan, Vietnam, and Singapore. OEP is headquartered in Taipei, Taiwan.

Orient Europharma Co Ltd Key Recent Developments

Feb 09,2021: Orient EuroPharma acquires Equity Stake in Quantum Genomics

This comprehensive SWOT profile of Orient Europharma Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Orient Europharma Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Orient Europharma Co Ltd – Key Information
Orient Europharma Co Ltd – Overview
Orient Europharma Co Ltd – Key Employees
Orient Europharma Co Ltd – Key Employee Biographies
Orient Europharma Co Ltd – Key Operational Heads
Orient Europharma Co Ltd – Major Products and Services
Orient Europharma Co Ltd – History
Orient Europharma Co Ltd – Company Statement
Orient Europharma Co Ltd – Locations And Subsidiaries
Orient Europharma Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Orient Europharma Co Ltd – Business Description
Orient Europharma Co Ltd – Corporate Strategy
Orient Europharma Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Orient Europharma Co Ltd – Strengths
Orient Europharma Co Ltd – Weaknesses
Orient Europharma Co Ltd – Opportunities
Orient Europharma Co Ltd – Threats
Orient Europharma Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Orient Europharma Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Orient Europharma Co Ltd, Key Information
Orient Europharma Co Ltd, Key Ratios
Orient Europharma Co Ltd, Share Data
Orient Europharma Co Ltd, Major Products and Services
Orient Europharma Co Ltd, History
Orient Europharma Co Ltd, Key Employees
Orient Europharma Co Ltd, Key Employee Biographies
Orient Europharma Co Ltd, Key Operational Heads
Orient Europharma Co Ltd, Other Locations
Orient Europharma Co Ltd, Subsidiaries
Orient Europharma Co Ltd, Key Competitors
Orient Europharma Co Ltd, SWOT Analysis
Orient Europharma Co Ltd, Ratios based on current share price
Orient Europharma Co Ltd, Annual Ratios
Orient Europharma Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Orient Europharma Co Ltd (4120):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Asahi Kasei Corporation:企業のM&A・事業提携・投資動向
    Asahi Kasei Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Asahi Kasei Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Organo Corporation:企業の戦略・SWOT・財務情報
    Organo Corporation - Strategy, SWOT and Corporate Finance Report Summary Organo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Solvay Specialty Polymers Italy SpA:企業の戦略的SWOT分析
    Solvay Specialty Polymers Italy SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Regulus Therapeutics Inc (RGLS)-医療機器分野:企業M&A・提携分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a developer of microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target microRNAs. Its products are used for the ther …
  • Blue Energy Ltd (BUL):企業の財務・戦略的SWOT分析
    Summary Blue Energy Ltd (BEL) is an oil and gas company that provides exploration and development services. The company provides exploration and production of coal seam gas and conventional oil, and gas resources in Australia. Its projects portfolio includes Carpentaria basin, Bowen basin, galilee b …
  • University Hospitals-製薬・医療分野:企業M&A・提携分析
    Summary University Hospitals is a healthcare service provider that offers patient-centered medical care and education services. The center includes network of specialty care physicians, skilled nursing, elder health, rehabilitation and home care services, managed care and insurance programs, occupat …
  • Comrod Communication ASA:企業の戦略・SWOT・財務情報
    Comrod Communication ASA - Strategy, SWOT and Corporate Finance Report Summary Comrod Communication ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Abu Dhabi National Hotels Company:企業の戦略・SWOT・財務分析
    Abu Dhabi National Hotels Company - Strategy, SWOT and Corporate Finance Report Summary Abu Dhabi National Hotels Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • California Resources Corp (CRC):企業の財務・戦略的SWOT分析
    California Resources Corp (CRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • WInckworth Sherwood LLP:企業の戦略的SWOT分析
    WInckworth Sherwood LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Trustpower Limited (TPW)-エネルギー分野:企業M&A・提携分析
    Summary TrustPower Limited (Trustpower) is an energy utility that retails electricity, gas and telecommunication services. The company produces electricity from wind, hydro, and diesel sources. It owns and operates various power projects across New Zealand and Australia. Trustpower also leases elect …
  • Oncolix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Oncolix Inc (Oncolix) is a clinical stage biopharmaceutical company. It is developing a targeted therapeutic protein, Prolanta for the treatment of ovarian, breast and other cancers. Prolanta is a recombinant analogue to the human prolactin and acts as an antagonist to the prolactin receptor …
  • Ameren Corporation:企業の戦略・SWOT・財務情報
    Ameren Corporation - Strategy, SWOT and Corporate Finance Report Summary Ameren Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Monsanto Co (MON):企業の財務・戦略的SWOT分析
    Monsanto Co (MON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Hal Trust:企業の戦略・SWOT・財務分析
    Hal Trust - Strategy, SWOT and Corporate Finance Report Summary Hal Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Moorim SP Co., Ltd.:企業の戦略・SWOT・財務情報
    Moorim SP Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Moorim SP Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Neovasc Inc (NVCN)-医療機器分野:企業M&A・提携分析
    Summary Neovasc Inc (Neovasc) is a medical device company that develops, manufactures and sells products for cardiovascular disease. The company offers products such as tiara, reducer and tissue products. Its tiara is a novel transcatheter device that is designed for treating mitral regurgitation, a …
  • Univalor Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Univalor Inc (Univalor) is a university technology transfer organization that optimizes research outcomes by commercializing the technological innovations of researchers from health centers and academic institutions. The organization provides researcher services such as protecting intellectu …
  • Relief Therapeutics Holding AG (RLF):製薬・医療:M&Aディール及び事業提携情報
    Summary Relief Therapeutics Holding AG (Relief Therapeutics) is a drug development company that offers clinical development of peptides and proteins of natural or engineered origin. The company’s pipeline drug candidates include aviptadil for the treatment of sarcoidosis and low dose interleukin-6 t …
  • Kansas Electric Power Cooperative, Inc.:企業の戦略的SWOT分析
    Kansas Electric Power Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆